China Releases County-level Public Hospital Reform Guidelines
This article was originally published in PharmAsia News
The reforms will slash drug markups and promote the Essential Drug List and traditional Chinese medicine to control medical expenditures.
You may also be interested in...
SHANGHAI - Merck & Co. affiliate MSD signed an agreement to form a joint venture July 21 with Simcere Pharmaceutical Group that will see both companies expand access to critical lifestyle drugs across China
SHANGHAI - China's pharma market is expected to continue to grow in the next five years with a CAGR of 23.2%, which will be backed largely by the expansion of community health centers across tier 2 and tier 3 cities, according to a report issued by consultancy IMS Health
As China is poised to supply medical products to fight the coronavirus around the world, a battle to banish its image of poor product quality is on.